Carlsmed, Inc.
NASDAQCarlsmed enters its May 7 earnings report with the Street firmly bullish in rating but quietly walking back targets — a gap that now defines the most interesting tension into the print. Covering analysts at Goldman Sachs and Truist Securities both trimmed price targets in April while keeping Buy ratings. Goldman cut from $19 to $17 on April 9; Truist followed on April 15, moving…
CARL short interest dropped 25.3% over one week to 2.1% of float, as borrow costs eased to 2.81% APR.
Snapshot as of 6 May 2026
Carlsmed enters its May 7 earnings report with the Street firmly bullish in rating but quietly walking back targets — a gap that now defines the most interesting tension into the print. Covering analysts at Goldman…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CARL — free to start on ORTEX.
Sign up for free →Open CARL on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CARL data →